Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 174 of 1,261
  1. US 11738085

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  2. US 11739068

    Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof

    KalVista Pharmaceuticals Limited · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  3. US 11739162

    Side chain modified peptoids useful as structure-stabilizing coatings for biomaterials

    The Regents of the University of California · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  4. US 11738015

    Pharmaceutical compositions and methods of using the same

    NODEN PHARMA DESIGNATED ACTIVITY COMPANY · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  5. US 11739309

    CRISPR-Cas12J effector polypeptides and methods of use thereof

    The Regents of the University of California · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  6. US 11738070

    Methods and compositions for improved cognition

    The Regents of the University of California · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  7. US 11739345

    Methods of treating phenylketonuria

    BIOMARIN PHARMACEUTICAL INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  8. US 11738053

    Methods and compositions for treating chronic granulomatous disease

    The Board of Regents of the University of Texas System · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  9. US 11737981

    Cellulosic polymer nanoparticles and methods of forming them

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  10. US 11737979

    Method of making lipid-encapsulated RNA nanoparticles

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  11. US 11737978

    Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease

    Northwestern University · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  12. US 11737983

    Storage stable sincalide formulations

    MAIA PHARMACEUTICALS, INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  13. US 11739297

    Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

    Carisma Therapeutics Inc. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  14. US 11738035

    Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

    Compass Pathfinder Limited · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  15. US 11738119

    Antimicrobial catheters

    The Board of Regents of the University of Texas System · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  16. US 11739074

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  17. US 11739152

    Antibodies which bind Fc receptors (FcRn)

    Takeda Pharmaceutical Company Limited · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  18. WO 2023156493

    FORMES CRISTALLINES DE NALTREXONE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Aug 24, 2023 · Expires Aug 19, 2043

    granted
  19. WO 2023158844

    COMPOSITIONS NUTRITIONNELLES EN POUDRE TRAITÉES THERMIQUEMENT ET PROCÉDÉS DE MAINTIEN DE (2S)-HESPÉRIDINE

    ABBOTT LAB [US] · Granted Aug 24, 2023 · Expires Aug 19, 2043

    granted
  20. WO 2023159093

    COMPOSITIONS NUTRITIONNELLES COMPRENANT DES OLIGOSACCHARIDES DE LAIT MATERNEL ET DE L'IMMUNOGLOBULINE BOVINE

    ABBOTT LAB [US] · Granted Aug 24, 2023 · Expires Aug 19, 2043

    granted
  21. US 11730828

    Gene therapy for haploinsufficiency

    The Regents of the University of California · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  22. US 11730739

    Treatment of congenital adrenal hyperplasia

    Neurocrine Biosciences, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  23. US 11730819

    Peptide derivatives having novel linkage structures

    BicycleTx Limited · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  24. US 11731977

    SGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.